Nebraska Blood and Marrow Transplant Research Network

Medicine & Life Sciences

1. Bone Marrow 100%
2. Transplants 85%
3. Stem Cell Transplantation 44%
4. Hematopoietic Stem Cell Transplantation 32%
5. Clinical Trials 32%
6. iodine-131 anti-B1 antibody 21%
7. Carmustine 16%
8. Tissue Donors 14%
9. Melphalan 14%
10. Cytarabine 13%
11. Rituximab 13%
12. Cell Transplantation 13%
13. Etoposide 12%
14. Infections 11%
15. trans-crotonin 10%
16. Multicenter Studies 10%
17. Immune Reconstitution 8%
18. Quality of Life 8%
19. Lenalidomide 8%
20. Physicians 7%
21. Recurrence 7%
22. Delivery of Health Care 7%
23. Phase III Clinical Trials 7%
24. Germinal Center 7%
25. Interleukin-2 Receptors 7%
26. Lymphoma, Large B-Cell, Diffuse 6%
27. Allogeneic Cells 6%
28. Graft vs Host Disease 6%
29. Random Allocation 5%
30. Progression-Free Survival 5%
31. Teaching 5%
32. Child 5%
33. Vascular Endothelial Growth Factor A 5%
34. Lymphoma 5%
35. Therapeutics 5%